1,361 followers
Emson, C. et al. CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of #tezepelumab on airway inflammation in patients with uncontrolled asthma. Respir Res 21, 265 (2020). https://t.co/NKDY8j2mqz